Immune-mediated diseases in cats including pemphigus, lupus, and immune polyarthritis require long-term management balancing disease control with treatment side effects. 2026 research is improving outcomes.
Cats with immune-mediated diseases face ongoing welfare challenges both from their disease and from the side effects of necessary immunosuppressive treatments. Advances in targeted immunomodulation and steroid-sparing treatments are improving the welfare balance of treatment, achieving disease control with fewer side effects. Regular quality of life assessment ensures treatment decisions reflect the cat's overall welfare.